R&B Medical Group,inc

R&B Medical Group,inc was paid $71K by Medicaid between Jul 2020 and Aug 2022, across 3 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 93% of everything it billed.

33Billing provider infoR&B MEDICAL GROUP,INC
VAN NUYS, CA 91406

33aNPI1528100336assigned 02/12/2007

33bProvider typeInternal Medicine Physician

28Total paid$71K

24GClaims2,037

24DCodes billed3

24AFirst – last monthJul 2020 – Aug 2022

Compared with peers

Next to other Internal Medicine Physician providers in California

Rank by total paid#761 of 2,679

Median peer was paid$13K

This provider vs. median5.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	364	$24K
2021	1,267	$36K
2022	406	$11K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	93%	1,321	1,041	$66K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	6.2%	693	540	$4K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	23	16	$211.14

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRASEKHI, MOHAMMAD (MEDICAL DIRECTOR)

Parent organizationR&M MEDICAL GROUP,INC.

Same official

Other billing entities under RASEKHI, MOHAMMAD

Full network →

Provider	Location	Paid
R&B Medical Group,inc.	El Monte, CA	$47K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.